Copeland Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Copeland Capital Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $74.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$74.9M
| Company | Shares | Value |
|---|---|---|
| DGXQuest Diagnostics Incorporated | 155,348 | $30.4M |
| LLYELI LILLY & Co | 18,730 | $17.2M |
| CORCencora Inc. | 42,245 | $13.3M |
| PMPhilip Morris International Inc | 66,703 | $11.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,449 | $1.1M |
| JNJJOHNSON & JOHNSON | 1,810 | $442K |
| ABBVAbbVie Inc. | 1,248 | $271K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 720 | $195K |
| ZTSZoetis Inc. | 1,570 | $186K |
| AMGNAMGEN INC | 400 | $141K |
| PFEPFIZER INC | 4,983 | $140K |
| ABTABBOTT LABORATORIES | 1,248 | $128K |
| PBIPROVENTION BIO, INC. | 6,646 | $73K |
| MRKMerck & Co., Inc. | 600 | $72K |
| UTMDUtah Medical Products Inc. | 1,059 | $66K |
| NRCNational Research Corporation Common Stock (Delaware) | 3,734 | $63K |
| LFVNLifevantage Corp | 4,712 | $20K |
| NVONovo Nordisk A/S | 186 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.